跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
按專業知識、姓名或所屬機構搜尋
放射線腫瘤部
國立成功大學
國立成功大學醫學院附設醫院
電話
886-6-2353535 Ext. 2461
電子郵件
[email protected]
網站
http://nckurt.weebly.com/
Postal address
在地圖上顯示
概覽
指紋
網路
概要
(6)
研究成果
(89)
指紋
查看啟用 放射線腫瘤部 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine & Life Sciences
Head and Neck Neoplasms
100%
Survival
64%
Radiotherapy
55%
Esophageal Squamous Cell Carcinoma
53%
Chemoradiotherapy
46%
Neoplasms
37%
Radiation
31%
Triple Negative Breast Neoplasms
29%
Squamous Cell Carcinoma
28%
Intensity-Modulated Radiotherapy
23%
Alcohols
22%
Nasopharyngeal Carcinoma
20%
Drug Therapy
20%
Alcohol Drinking
18%
Neck
17%
Oropharyngeal Neoplasms
17%
Copper Transporter 1
16%
Hypopharyngeal Neoplasms
16%
Platinum
15%
Fluorodeoxyglucose F18
15%
Confidence Intervals
15%
Therapeutics
14%
Mouth
13%
Non-Small Cell Lung Carcinoma
12%
Catenins
12%
Mouth Neoplasms
12%
Odds Ratio
12%
Genetic Polymorphisms
11%
Positron Emission Tomography Computed Tomography
11%
Long Noncoding RNA
10%
Tobacco Products
10%
Carcinogenesis
10%
Life Style
9%
Lymph Nodes
9%
Glioblastoma
9%
Tomography
9%
Serum
9%
Nasopharyngeal Neoplasms
8%
MicroRNAs
8%
Stomach Neoplasms
8%
Hypersensitivity
7%
Brain
7%
Hepatocellular Carcinoma
7%
Prostatic Neoplasms
7%
Metal Nanoparticles
7%
Adjuvant Chemoradiotherapy
7%
Tumor Burden
7%
Temozolomide
7%
Radium
7%
Monocrotaline
6%
Esophageal Fistula
6%
Anaplastic Thyroid Carcinoma
6%
Spine
6%
Survival Rate
6%
Registries
6%
Cell Plasticity
6%
Adjuvant Chemotherapy
6%
Keloid
6%
Genes
6%
Pharmaceutical Preparations
6%
Thyroid Gland
6%
Bone and Bones
6%
Drug and Narcotic Control
6%
Endosonography
6%
Papillomaviridae
5%
Prealbumin
5%
Sorafenib
5%
Stem Cells
5%
Nomograms
5%
Osteopontin
5%
Pericardial Effusion
5%
Pulmonary Arterial Hypertension
5%
Human papillomavirus 16
5%
Reactive Oxygen Species
5%
Down-Regulation
5%
Neoadjuvant Therapy
5%
Vegetables
5%
Frailty
5%
Machine Learning
5%
Genotype
5%
Endometrial Neoplasms
5%
Squamous Cell Carcinoma of Head and Neck
5%
Castration
5%
Radiosurgery
5%